| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1091025256 |
| P356 | DOI | 10.1038/S41598-017-06106-1 |
| P932 | PMC publication ID | 5548860 |
| P698 | PubMed publication ID | 28790338 |
| P50 | author | Jiankui He | Q59223278 |
| Zhoufang Li | Q100695175 | ||
| P2093 | author name string | Geng Tian | |
| Xiaohua Li | |||
| Bo Zhou | |||
| Fang Deng | |||
| Chaoyu Liu | |||
| Shixin Lu | |||
| Ligang Xia | |||
| Weiren Huang | |||
| Yuancai Xie | |||
| Hongyu Dai | |||
| Feiyue Xu | |||
| Xiaonian Tu | |||
| Lidong Zeng | |||
| P2860 | cites work | Extensive Variation in the Mutation Rate Between and Within Human Genes Associated with Mendelian Disease. | Q50717100 |
| Lung cancer: Using ctDNA to track EGFR and KRAS mutations in advanced-stage disease. | Q51728298 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Cancer genomics: A nucleosome footprint reveals the source of cfDNA | Q87151150 | ||
| Biomarkers: ctDNA-identifying cancer before it is clinically detectable | Q87155725 | ||
| cfDNA as a Prognostic Marker of Response to Taxane Based Chemotherapy in Patients with Prostate Cancer | Q87157668 | ||
| ctDNA is a specific and sensitive biomarker in multiple human cancers | Q87625205 | ||
| Analysis of genetic inheritance in a family quartet by whole-genome sequencing | Q22065898 | ||
| Cancer genome landscapes | Q22242276 | ||
| Rates of spontaneous mutation | Q24548000 | ||
| Estimate of the mutation rate per nucleotide in humans | Q24548130 | ||
| Emerging technologies for salivaomics in cancer detection | Q28069566 | ||
| Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis | Q28386212 | ||
| Time-to-Progression of NSCLC from Early to Advanced Stages: An Analysis of data from SEER Registry and a Single Institute | Q31110762 | ||
| Landscape of somatic mutations in 560 breast cancer whole-genome sequences | Q34046731 | ||
| Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes | Q34356721 | ||
| Integrated digital error suppression for improved detection of circulating tumor DNA | Q34520008 | ||
| Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin | Q35752935 | ||
| Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer | Q35820329 | ||
| Individualized Mutation Detection in Circulating Tumor DNA for Monitoring Colorectal Tumor Burden Using a Cancer-Associated Gene Sequencing Panel | Q35884196 | ||
| Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology | Q37014663 | ||
| ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy | Q37662351 | ||
| Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer | Q37709148 | ||
| Next generation sequencing reveals genetic landscape of hepatocellular carcinomas | Q38051922 | ||
| Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging Technologies | Q38390077 | ||
| Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA. | Q40116927 | ||
| Breast cancer: Tracking ctDNA to evaluate relapse risk. | Q48651745 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | statistics | Q12483 |
| P304 | page(s) | 7526 | |
| P577 | publication date | 2017-08-08 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Statistical analysis of mutant allele frequency level of circulating cell-free DNA and blood cells in healthy individuals | |
| P478 | volume | 7 |
| Q93122680 | Life and death of circulating cell-free DNA |
| Q49740946 | Liquid Biopsy in Clinical Management of Breast, Lung, and Colorectal Cancer |
| Q92767070 | Mutations found in cell-free DNAs of patients with malignant lymphoma at remission can derive from clonal hematopoiesis |
| Q90331376 | Noninvasive cancer biomarkers in solid malignancies: circulating tumor DNA-clinical utility, current limitations and future perspectives |
| Q93077051 | Resectable lung lesions malignancy assessment and cancer detection by ultra-deep sequencing of targeted gene mutations in plasma cell-free DNA |
| Q92721586 | Single-molecule detection of cancer mutations using a novel PCR-LDR-qPCR assay |
| Q89525803 | The potential of combined mutation sequencing of plasma circulating cell-free DNA and matched white blood cells for treatment response prediction |
| Q90884383 | eVIDENCE: a practical variant filtering for low-frequency variants detection in cell-free DNA |
Search more.